Page last updated: 2024-09-03

technetium tc 99m etidronate and Prostatic Neoplasms, Castration-Resistant

technetium tc 99m etidronate has been researched along with Prostatic Neoplasms, Castration-Resistant in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Alshehri, AHD; Campfield, C; Cole, AJ; Jain, SFP; O'Sullivan, JM; Osman, SOS; Prise, KM; Turner, PG1

Other Studies

1 other study(ies) available for technetium tc 99m etidronate and Prostatic Neoplasms, Castration-Resistant

ArticleYear
A novel tool for improving the interpretation of isotope bone scans in metastatic prostate cancer.
    The British journal of radiology, 2020, Nov-01, Volume: 93, Issue:1115

    Topics: Aged; Aged, 80 and over; Bone and Bones; Bone Neoplasms; Etidronic Acid; Humans; Male; Middle Aged; Organotechnetium Compounds; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Radiopharmaceuticals; Regression Analysis; Software Design; Tumor Burden; Urinary Bladder

2020